Tharimmune

Tharimmune

Biotechnology company(THAR)

О Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Инвесторы

Liberty City VenturesLiberty City Ventures
DRW Venture CapitalDRW Venture Capital
KrakenKraken
PolychainPolychain
A
ARK Invest

Подробности сбора средств

Раунд финансированияСуммаОценка
Date
Инвесторы
IPO
₽43.50B
--
2025-11-03
Liberty City VenturesLiberty City Ventures*
DRW Venture CapitalDRW Venture Capital*
+ 3